Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 4,487 shares at $23.81 ($107K) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Seasonal sale ($107k) by Chief Financial Officer — this insider has traded IMVT in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.81 | 2,189 | $52K | 48.8% |
| 2 | $23.81 | 2,189 | $52K | 48.8% |
| 3 | $24.19 | 109 | $3K | 2.5% |
| Total | $23.82 avg | 4,487 | $107K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |
| IMVT | SELL | 2024-11-22 | $212K | — | Filing → |